Autolus Therapeutics plc (AUTL) (CIK 0001730463) (AUTL)
Activity window: Nov. 12, 2025 to Nov. 11, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Oct. 24, 2026. Latest filing activity: May. 1, 2026. These dates describe different events.
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| May. 1, 2026 | CORRESP | Neutral/Informational | Moderate | Autolus Therapeutics plc has submitted a request to the SEC for the acceleration of their Registration Statement on Form S-3, seeking to have it become effective on May 5, 2026, a… | Read Filing EDGAR |
| May. 1, 2026 | CORRESP | Neutral/Informational | Moderate | Autolus Therapeutics plc has submitted a request to the SEC for the acceleration of their Registration Statement on Form S-3, seeking to have it declared effective on May 5, 2026,… | Read Filing EDGAR |
| Apr. 15, 2026 | UPLOAD | Neutral/Informational | Low | The SEC correspondence indicates that they have not reviewed and will not review Autolus Therapeutics plc's registration statement filed on April 13, 2026. The letter emphasizes t… | Read Filing EDGAR |
| Apr. 15, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Autolus Therapeutics plc that they will not review the company's registration statement filed on April 13, 2026. This decision emphasizes the company's… | Read Filing EDGAR |